Company intelligence / Profile preview

Immunofoco

Shanghai, Shanghai, Chinaimmunofoco.com ↗

Ownership: Private
Development stage: Phase 1

Overview

Immunofoco is a clinical-stage biotech company developing innovative immune cell therapies for solid tumors. Its lead program IMC001 has shown a favorable safety profile with a disease control rate of 90% in early trials; IMC002 has received Orphan Drug Designation from the FDA and IND approvals in both China and the US. The company’s pipeline leverages proprietary platforms to address tumor heterogeneity and improve efficacy/safety of cell therapy products.

Therapeutic areas: Oncology
Modalities: CAR-T cell therapies (Chimeric Antigen Receptor T-cell therapies)In vivo CAR-T platforms using lentiviral technologyRNAi-based therapeutics (Peri Cruiser® platform)
Industry: Biotech

Drug pipeline

14 assets

IMC001

13 more assets in the full pipeline.

Request access →

Partnerships

Collaborations with clinical organizations, hospitals, research institutesScience & Technology Commission of Shanghai (funded by)Chengdu Capital Group (investor)

Beyond the preview

Go deeper on Immunofoco.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunofoco.

Explore the full profile